Yuki Arakawa

987 citations
31 papers · 201 indexed · h-index 7
Topics
Acute Lymphoblastic Leukemia research (11 papers)Acute Myeloid Leukemia Research (7 papers)Childhood Cancer Survivors' Quality of Life (5 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
Partner nations
JapanItalySingapore

In The Last Decade

Yuki Arakawa

23 papers receiving 198 citations

Peers

Yuki Arakawa
Comparison fields: 5 of 51
  • Oncology 67
  • Neurology 63
  • Hematology 37
  • Genetics 36
  • Immunology 32
Replace Selmin Ataergın with:
Selmin Ataergın Türkiye
Yasir Khan United States
Ömür Gökmen Sevindik Türkiye
Maurizio Lalle Italy
Catherine Vézina Canada
Corentin Orvain France
Sharon Bergeron United States
Mattia Congia Italy
Maaike de Bie Netherlands
Shoko Nakayama Japan
Yuki Arakawa relative to Selmin Ataergın Türkiye Selmin Ataergın's profile →
Citations per field
00.5×7.5×
Selmin Ataergın · 1×
Citations per year

Countries citing papers authored by Yuki Arakawa

Since Specialization
Citations

This map shows the geographic impact of Yuki Arakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Arakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Arakawa more than expected).

Fields of papers citing papers by Yuki Arakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Arakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Arakawa. The network helps show where Yuki Arakawa may publish in the future.

Co-authorship network of co-authors of Yuki Arakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Arakawa. A scholar is included among the top collaborators of Yuki Arakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Arakawa. Yuki Arakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 0
3 0
4 4
5 0
6 0
7 3
8 2
9 1
10 6
11 9
12 28
13 0
14 4
15 20
16 3
17 16
18 0
19 2
20 2

About Yuki Arakawa

Yuki Arakawa is a scholar working on Hematology, Genetics and Neurology, having authored 31 papers that have together received 201 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (7 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). The work is most often cited by research in Neurology (63 citations), Genetics (36 citations) and Hematology (37 citations). Yuki Arakawa has collaborated with scholars based in Japan, Italy and Singapore. Frequent co-authors include Katsuyoshi Koh, Ryoji Hanada, Makiko Mori, Hiroshi Kawashima, Takahiro Aoki, Hiroshi Kishimoto, Moeko Hino, Shinichiro Motohashi, Naoki Shimojo and Kentaro Watanabe. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026